Company profile

Paige

paige.aiHeadquarters: United States
51-200 employeesProduct Vendor
Paige logo

Primary focus

Computational pathology solutions using large-scale image and multimodal foundation models for whole-slide image analysis, biomarker prediction, and diagnostic workflow support.

Why it’s included

The company develops and offers 'FullFocus', an FDA-cleared whole-slide image viewer and digital pathology platform, as well as multiple AI applications for whole-slide tissue image analysis, directly addressing digitized-tissue pathology workflows and regulatory requirements.

Relevant capabilities

  • Whole-slide image analysis for cancer detection, grading, and subtyping
  • High-throughput biomarker prediction from H&E
  • Multimodal data integration and automated clinical report generation
  • Platform integration, deployment, and image management
  • Foundation model development and licensing
Commercial sectorAI-Powered Diagnostic & Decision Support Algorithms
Technology classesImage management systems for digital pathology, Vision transformer pathology image analysis, Cloud-based pathology image analysis platforms, Pathology image compression and format conversion, CNN-based pathology image analysis algorithms, Stain normalization and color calibration, AI training data curation for pathology, Telepathology and remote consultation systems

Relevant commercial products

  • Virchow
  • Paige PanCancer Suite
  • FullFocus
  • Pan-tissue cancer detection application
  • Paige OmniScreen

Relevant patents

4 families, 5 publications
  • Systems and methods for processing electronic images for computational detection methods US-11995903-B2
  • Systems and methods for processing electronic images US-11210787-B1
  • Systems and methods for processing electronic images to infer biomarkers US-12387330-B2
  • Systems and methods of automatically processing electronic images across regions US-11791036-B2

← Back to what’s inside this report